1	subject have a stable dose regimen of 1 to 3 market antiepileptic drug s aeds with or without additional concurrent stable vagus nerve stimulation vns the vns must have be in place for at least 6 month prior to study entry with constant setting for at least 28 day prior to the screening visit and during|antiepileptic[52,65]|||||||6 month[194,201]||C0003299|932|932|antiepileptic
2	the baseline phase benzodiazepine will be count a an aed|benzodiazepine[324,338]||||||||||1402|1402|benzodiazepine
